TCL Archive Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials March 26, 1993
TCL Archive Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says August 19, 1994